Results 1 to 10 of about 1,346 (172)
Cell therapy in vascularized composite allotransplantation
Allograft rejection is one of the obstacles in achieving a successful vascularized composite allotransplantation (VCA). Treatments of graft rejection with lifelong immunosuppression (IS) subject the recipients to a lifelong risk of cancer development and
Madonna Rica Anggelia +5 more
doaj +5 more sources
Unraveling the Roles of Macrophages in Vascularized Composite Allotransplantation [PDF]
The phenotypic heterogeneity and functional diversity of macrophages have been increasingly appreciated, particularly regarding their roles as innate immune cells in shaping transplantation outcomes.
Hui-Yun Cheng +2 more
doaj +4 more sources
Perfusion decellularization for vascularized composite allotransplantation
Vascularized composite allotransplantation is becoming the emerging standard for reconstructive surgery treatment for patients with limb trauma and facial injuries involving soft tissue loss.
Danielle L Nicholls +3 more
doaj +4 more sources
A Guide to the Implementation and Design of Ex Vivo Perfusion Machines for Vascularized Composite Allotransplantation [PDF]
Background:. Ex vivo machine perfusion (EVMP) is a versatile platform utilized in vascularized composite allotransplantation (VCA) to prolong preservation, salvage tissue, and evaluate graft viability. However, there is no consensus on best practices for
Tessa E. Muss, MD +8 more
doaj +3 more sources
Where Do We Stand for Nerve Regeneration and Functional Recovery After Vascularized Composite Allotransplantation? [PDF]
ABSTRACT Introduction Vascularized composite allotransplantation (VCA) offers a reconstructive solution for patients with severe limb and facial defects by transplanting multiple tissue types—including skin, muscle, bone, and nerves—as a single unit.
Mathieu O +7 more
europepmc +2 more sources
Vascularized composite allotransplantation represents the final level of the reconstructive ladder, offering treatment options for severe tissue loss and functional deficiencies.
Shaishav Datta +2 more
doaj +2 more sources
As clinical experience with surgical techniques and immunosuppression in vascularized composite allotransplantation recipients has accumulated, vascularized composite allotransplantation for hand and face have become standard of care in some countries ...
Yoram Y Fleissig +3 more
doaj +2 more sources
Vascularized composite tissue allotransplantation – state of the art [PDF]
AbstractVascularized composite tissue allotransplantation is a viable treatment option for injuries and defects that involve multiple layers of functional tissue. In the past 15 yr, more than 150 vascularized composite allotransplantation (VCA) surgeries have been reported for various anatomic locations including – but not limited to – trachea, larynx,
J Rodrigo Diaz-Siso +2 more
exaly +3 more sources
In this article, we present a report from a national meeting titled, “Evolving Issues of Vascularized Composite Allotransplantation—A Symposium on Ethics, Policy, and Reimbursement Issues,” which convened in September 2017.
John Rose +12 more
doaj +2 more sources
Immunogenicity and tolerance induction in vascularized composite allotransplantation. [PDF]
Vascularized composite allotransplantation (VCA) is the transplantation of multiple tissues such as skin, muscle, bone, nerve, and vessels, as a functional unit (i.e., hand or face) to patients suffering from major tissue trauma and functional deficits. Though the surgical feasibility has been optimized, issues regarding graft rejection remains.
Sun JA, Adil A, Biniazan F, Haykal S.
europepmc +4 more sources

